A Pilot Study of Temozolomide and 06Benzylguanine for Treatment of Newly Diagnosed High Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection
Phase of Trial: Phase I
Latest Information Update: 28 Aug 2012
At a glance
- Drugs Temozolomide (Primary) ; Benzylguanine
- Indications Glioma
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 28 Aug 2012 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 01 Aug 2012 Planned end date changed from 1 Dec 2008 to 1 Dec 2012 as reported by ClinicalTrials.gov.